Related Experiment Video
Updated: Jun 17, 2026
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
Immune responses to malignancies
1University of Pittsburgh Cancer Institute and Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. whitesidetl@msx.upmc.edu
Abstract:
Immune responses to tumor-associated antigens (TAs) are often detectable in tumor-bearing hosts, but they fail to eliminate malignant cells or prevent the development of metastases. Patients with cancer generate robust immune responses to infectious agents (bacteria and viruses) perceived as a "danger signal" but only ineffective weak responses to TAs, which are considered as "self." This fundamental difference in responses to self versus nonself is further magnified by the ability of tumors to subvert the host immune system. Tumors induce dysfunction and apoptosis in CD8(+) antitumor effector cells and promote expansion of regulatory T cells, myeloid-derived suppressor cells, or both, which downregulate antitumor immunity, allowing tumors to escape from the host immune system. The tumor escape is mediated by several distinct molecular mechanisms. Recent insights into these mechanisms encourage expectations that a more effective control of tumor-induced immune dysfunction will be developed in the near future. Novel strategies for immunotherapy of cancer are aimed at the protection and survival of antitumor effector cells and also of central memory T cells in the tumor microenvironment.
Insights
Cancer immune responses to tumor antigens are weak and ineffective, unlike responses to pathogens. Tumors actively suppress anti-cancer immunity, enabling immune escape. Future immunotherapies aim to overcome this dysfunction for better cancer control.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Immune responses to tumor-associated antigens (TAs) are often insufficient to eliminate cancer cells.
- Cancer patients mount strong immune responses to pathogens but weak responses to self-antigens like TAs.
- Tumors exploit immune system weaknesses, promoting immune evasion and metastasis.
Purpose of the Study:
- To explain why the immune system fails against cancer.
- To investigate tumor mechanisms of immune subversion.
- To highlight potential new strategies for cancer immunotherapy.
Main Methods:
- Analysis of immune responses to self versus non-self antigens.
- Investigation of tumor-induced immune cell dysfunction (CD8+ T cells).
- Examination of immune-suppressive cell expansion (regulatory T cells, myeloid-derived suppressor cells).
Main Results:
- Tumors induce dysfunction and apoptosis in CD8+ effector cells.
- Tumors promote the expansion of regulatory T cells and myeloid-derived suppressor cells.
- These mechanisms allow tumors to escape host immune surveillance.
Conclusions:
- Tumor immune escape is mediated by distinct molecular mechanisms.
- Understanding these mechanisms is key to developing effective cancer immunotherapies.
- Future strategies will focus on protecting anti-tumor effector and memory T cells within the tumor microenvironment.
Related Concept Videos
01:40Cell-mediated Immune Responses
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:27Tumor Immunotherapy
01:26Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:27Allergic Drug Reactions
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...